2023 - UAT and Risk Mitigation: Insights from Global Technology Experts and Cutting-Edge Pharma
Date2023-09-07
Deadline2023-09-07
VenueWebinar, USA - United States
KeywordsRisk Management; Risk Mitigation; UAT
Topics/Call fo Papers
In the dynamic landscape of clinical trials, ensuring efficient and compliant User Acceptance Testing (UAT) processes while mitigating risks is crucial. In this engaging webinar, leading technology vendors, 4G Clinical and Poxy Clinical, collaborated with renowned pharmaceutical company, Vir Biotechnology, to present their approach in supporting complex trial UAT. The webinar will explore the interpretation of regulations, the implementation of GAMP 5 guidelines and the integration of best practices from this partnership. This insightful webinar aims to assist sponsors on their UAT journey while minimizing potential risks.
During the webinar, the featured speakers will also highlight how efficient and enhanced UAT processes allow sponsors to concentrate on core aspects of the trial. By fostering a more efficient and inclusive UAT experience, this collaborative approach not only supports risk mitigation efforts but also contributes to optimized and compliant clinical trials.
Join the speakers to gain valuable insights and strategies for enhancing UAT processes while minimizing risks.
During the webinar, the featured speakers will also highlight how efficient and enhanced UAT processes allow sponsors to concentrate on core aspects of the trial. By fostering a more efficient and inclusive UAT experience, this collaborative approach not only supports risk mitigation efforts but also contributes to optimized and compliant clinical trials.
Join the speakers to gain valuable insights and strategies for enhancing UAT processes while minimizing risks.
Other CFPs
- Long-Acting Injectables (LAI): Microsphere Design, Development and Scale-up
- Accurate Suicide Risk Detection with eC-SSRS Helps Ensure Safety of Trial Participants and Treatments in Oncology and Beyond
- Using AI in Drug Development to Enhance Preclinical Translatability
- Introducing Automated Parallel Peptide Purification with the PurePep® EasyClean Auto Kit
- ADME and Drug-Drug Interaction Considerations During Drug Development
Last modified: 2023-07-29 06:16:39